Abstract
Introduction
The effects of squamous and/or glandular differentiation in urothelial carcinoma of bladder on recurrence, progression and survival rate were evaluated in this study.
Patients and methods
Between 1998 and 2003, a total of 223 patients who had been treated with transurethral resection for bladder cancers were evaluated. The patients were divided into two groups as; Group I: tumor patients with squamous and/or glandular differentiation, Group II: patients without these findings.
Results
Histologically 189 (84.7%) were conventional urothelial carcinoma and 34 (15.2%) were tumors with squamous and/or glandular differentiation. The mean age of the patients was 64.4 ± 12.7 (range 36–81) years. Survival rates within a period of 46.23 ± 14.8 (12–67) months were 76.47% for Group I and 89.94% for Group II (P = 0.027). The stage distribution as pTa, pT1, and ≥pT2 was 2 (5.9%), 18 (52.9%), and 14 (41.2%) in Group I and 101 (53.4%), 51 (27%) and 37 (19.6%) in group II, respectively (P = 0.001). There was a statistically significant tendency towards higher stage at presentation in Group I and the grade distribution was significantly higher in Group I than Group II (P < 0.001).
Conclusion
High recurrence rates and poor prognosis of these patients should be kept in mind in the follow-up period. In this respect, these patients should be followed up closely.
Similar content being viewed by others
References
Guo CC, Fine SW, Epstein JI (2006) Noninvasive squamous lesions in the urinary bladder. A clinicopathologic analysis of 29 cases. Am J Surg Pathol 30:883–891
Sakamoto N, Tsuneyoshi M, Enjoji M (1992) Urinary bladder carcinoma with neoplastic squamous component: a mapping study of 31 cases. Histopathology 21:135–141
Young RH, Eble JN (1990) Unusual forms of carcinoma of the urinary bladder. Human Pathol 22:948–965
Kaye KW, Lange PH (1982) Mode of presentation of invasive bladder cancer: reassessment of the problem. J Urol 128:31–33
Raghavan D, Shipley WU, Garnick MB (1990) Biology and management of the bladder cancer. N Engl J Med 322:1129–1138
International Union Against Cancer (1997) TNM. Classification of malignant tumours, 5th edn. Wiley-Liss, New York, pp 187–190
Mostofi FK, Sobin LH, Torlini H (1973) Histologic typing of urinary bladder tumours. World Health Organization, Geneva, pp 1–20
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumors. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 90–99
Ayala AG, Ro JY (1989) Premalignant lesions of the urothelium and transitional cell tumors. In: Young RH (ed) Pathology of the urinary bladder. Churchill Livingstone, New York, NY, pp 65–101
Marin JE, Jenkins BJ, Zuk RJ (1989) Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol 42:250–253
Young RH (2001) Pathology of carcinomas of the urinary bladder. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Comprehensive textbook of genitourinary oncology, 2nd edn. LippincottWilliams ( Wilkins, pp 310–321
Pugh RCB (1959) The pathology of bladder tumours. In: Wallace DW (ed) Tumours of the bladder, vol. II. In: Smithers DW (ed) Neoplastic disease at various sites. London: E ( S Livingstone
Young RH, Zukerberg L (1991) Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol 96:635–639
McGovern VJ (1969) The histological classification of bladder tumors. Pathology 1:255–264
Frazier AF, Robertson JE, Dodge RK, Paulson DF (1993) The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71:3993–4001
Akdas A, Turkeri L (1991) The impact of squamous metaplasia in transitional cell carcinoma of the bladder. Int Urol Nephrol 23:333–336
Young RH, Oliva E (1996) Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. Am J Surg Pathol 20:1448–1454
Logothesis CJ, Dexeus FH, Chong C (1989) Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors. The MD Anderson experience. J Urol 141:33–37
Genega EM, Hutchinson B, Hashibe M (2000) Urothelial carcinoma with aberrant differentiation: incidence and clinical significance. Mod Pathol 13:100
Billis A, Schenka AA, Carlos COR, Carneiro LT, Araujo V (2001) Squamous and/or glandular differentiation in urothelial carcinoma: prevalance and significance in transurethral resections of the bladder. Int J Urol and Nephrol 33:631–633
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erdemir, F., Tunc, M., Ozcan, F. et al. The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder. Int Urol Nephrol 39, 803–807 (2007). https://doi.org/10.1007/s11255-006-9151-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-006-9151-0